• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中毒性表皮坏死松解症:发病机制与治疗的综述。

Toxic epidermal necrolysis: review of pathogenesis and management.

机构信息

The University of Sydney, Sydney, New South Wales, Australia.

出版信息

J Am Acad Dermatol. 2012 Jun;66(6):995-1003. doi: 10.1016/j.jaad.2011.09.029. Epub 2011 Dec 9.

DOI:10.1016/j.jaad.2011.09.029
PMID:22169256
Abstract

Toxic epidermal necrolysis (TEN) is a severe cutaneous drug reaction with a mortality rate of approximately 30%. The hallmark of TEN is widespread epidermal sloughing due to keratinocyte apoptosis. Multiple genetic associations between TEN and specific ethnic populations have been determined. The pathophysiology of TEN has yet to be fully elucidated; however, current pathogenic models implicate Fas ligand, granulysin, and reactive oxygen species. The value of current therapies, such as intravenous immunoglobulin and corticosteroids, remains under evaluation.

摘要

中毒性表皮坏死松解症(TEN)是一种严重的皮肤药物反应,死亡率约为 30%。TEN 的特征是由于角质形成细胞凋亡导致广泛的表皮脱落。已经确定 TEN 与特定种族群体之间存在多种遗传关联。TEN 的病理生理学尚未完全阐明;然而,目前的发病机制模型涉及 Fas 配体、颗粒溶素和活性氧。目前疗法的价值,如静脉注射免疫球蛋白和皮质类固醇,仍在评估中。

相似文献

1
Toxic epidermal necrolysis: review of pathogenesis and management.中毒性表皮坏死松解症:发病机制与治疗的综述。
J Am Acad Dermatol. 2012 Jun;66(6):995-1003. doi: 10.1016/j.jaad.2011.09.029. Epub 2011 Dec 9.
2
Immunohistochemical evaluation of toxic epidermal necrolysis treated with human intravenous immunoglobulin.用人静脉注射免疫球蛋白治疗中毒性表皮坏死松解症的免疫组织化学评估
G Ital Dermatol Venereol. 2008 Aug;143(4):229-33.
3
Toxic epidermal necrolysis.中毒性表皮坏死松解症
J Am Acad Dermatol. 2007 Feb;56(2):181-200. doi: 10.1016/j.jaad.2006.04.048.
4
[Use of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis and Stevens-Johnson/toxic epidermal necrolysis overlap syndrome. Review of 15 cases].[静脉注射免疫球蛋白治疗中毒性表皮坏死松解症及史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症重叠综合征。15例病例回顾]
Rev Med Chil. 2009 Mar;137(3):383-9. Epub 2009 Jun 15.
5
Intravenous immunoglobulins and plasmapheresis combined treatment in patients with severe toxic epidermal necrolysis: preliminary report.静脉注射免疫球蛋白和血浆置换联合治疗重症中毒性表皮坏死松解症患者:初步报告
Br J Plast Surg. 2005 Jun;58(4):504-10. doi: 10.1016/j.bjps.2004.12.007.
6
An update on Stevens-Johnson syndrome and toxic epidermal necrolysis in children.儿童史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的最新进展。
Curr Opin Pediatr. 2009 Aug;21(4):505-10. doi: 10.1097/MOP.0b013e32832d1fef.
7
Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding.静脉注射免疫球蛋白在中毒性表皮坏死松解症和史蒂文斯-约翰逊综合征中的应用:我们目前的认识
Int Immunopharmacol. 2006 Apr;6(4):543-9. doi: 10.1016/j.intimp.2005.11.012. Epub 2005 Dec 19.
8
Toxic epidermal necrolysis: current evidence, practical management and future directions.中毒性表皮坏死松解症:当前证据、实际管理及未来方向
Br J Dermatol. 2005 Aug;153(2):241-53. doi: 10.1111/j.1365-2133.2005.06721.x.
9
Toxic epidermal necrolysis (Lyell's disease).中毒性表皮坏死松解症(莱尔氏病)。
Burns. 2010 Mar;36(2):152-63. doi: 10.1016/j.burns.2009.06.213. Epub 2009 Sep 18.
10
Beneficial therapeutic effect of plasmapheresis after unsuccessful treatment with corticosteroids in two patients with severe toxic epidermal necrolysis.两名重症中毒性表皮坏死松解症患者在接受皮质类固醇治疗失败后进行血浆置换取得了有益的治疗效果。
Ther Apher Dial. 2010 Jun;14(3):354-7. doi: 10.1111/j.1744-9987.2009.00800.x.

引用本文的文献

1
The Prevalence of Stevens-Johnson Syndrome Complications due to Antiepileptic Drug Use: A Systematic Review and Meta-Analysis.抗癫痫药物使用导致史蒂文斯-约翰逊综合征并发症的患病率:一项系统评价和荟萃分析。
Int J Prev Med. 2025 Jul 30;16:41. doi: 10.4103/ijpvm.ijpvm_132_24. eCollection 2025.
2
Immune-Related Cutaneous Adverse Events Display Distinct Clinical and Molecular Characteristics, Depending on Immune Checkpoints Targeted.免疫相关皮肤不良事件根据所靶向的免疫检查点不同,呈现出不同的临床和分子特征。
Cancers (Basel). 2025 Jun 14;17(12):1992. doi: 10.3390/cancers17121992.
3
A review of the immunogenetics of Stevens-Johnson syndrome and toxic epidermal necrolysis.
史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的免疫遗传学综述。
Glob Med Genet. 2025 May 7;12(3):100054. doi: 10.1016/j.gmg.2025.100054. eCollection 2025 Sep.
4
Serum Concentrations of IL-18, IL-21, IL-22, IL-23, IL-27, and IL-31 in Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis and Their Correlation With Disease Severity.史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症患者血清中白细胞介素-18、白细胞介素-21、白细胞介素-22、白细胞介素-23、白细胞介素-27和白细胞介素-31的浓度及其与疾病严重程度的相关性。
Med Arch. 2025;79(1):9-14. doi: 10.5455/medarh.2025.79.9-14.
5
T helper 2 cell-directed immunotherapy eliminates precancerous skin lesions.辅助性T细胞2型定向免疫疗法可消除癌前皮肤病变。
J Clin Invest. 2025 Jan 2;135(1):e183274. doi: 10.1172/JCI183274.
6
Spatial proteomics identifies JAKi as treatment for a lethal skin disease.空间蛋白质组学鉴定 JAKi 是治疗致命皮肤病的方法。
Nature. 2024 Nov;635(8040):1001-1009. doi: 10.1038/s41586-024-08061-0. Epub 2024 Oct 16.
7
Evaluation of the Factors Influencing Mortality in Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Multicenter Study of 166 Patients.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症患者死亡率影响因素的评估:一项对166例患者的多中心研究
Dermatol Ther (Heidelb). 2024 Jun;14(6):1547-1560. doi: 10.1007/s13555-024-01180-6. Epub 2024 May 17.
8
Albumin: a comprehensive review and practical guideline for clinical use.白蛋白:临床应用的全面综述与实用指南。
Eur J Clin Pharmacol. 2024 Aug;80(8):1151-1169. doi: 10.1007/s00228-024-03664-y. Epub 2024 Apr 12.
9
To Debride or Not to Debride: A Review of Wound Management for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.清创还是不清创:史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症伤口处理的综述
Cureus. 2024 Mar 1;16(3):e55350. doi: 10.7759/cureus.55350. eCollection 2024 Mar.
10
Effectiveness of early treatment with plasma exchange in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.血浆置换早期治疗对史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症患者的疗效。
Sci Rep. 2024 Feb 5;14(1):2893. doi: 10.1038/s41598-024-53653-5.